216 related articles for article (PubMed ID: 34093563)
1. Case Report: A Rare Case of Autoinflammatory Phospholipase Cγ2 (PLCγ2)-Associated Antibody Deficiency and Immune Dysregulation Complicated With Gangrenous Pyoderma and Literature Review.
Wu N; Zhang B; Wang T; Shen M; Zeng X
Front Immunol; 2021; 12():667430. PubMed ID: 34093563
[TBL] [Abstract][Full Text] [Related]
2. Novel
Neves JF; Doffinger R; Barcena-Morales G; Martins C; Papapietro O; Plagnol V; Curtis J; Martins M; Kumararatne D; Cordeiro AI; Neves C; Borrego LM; Katan M; Nejentsev S
Front Immunol; 2018; 9():2863. PubMed ID: 30619256
[No Abstract] [Full Text] [Related]
3. Clinical and immunological features of an APLAID patient caused by a novel mutation in
Peng Q; Luo D; Yang Y; Zhu Y; Luo Q; Chen H; Chen D; Zhou Z; Lu X
Front Immunol; 2023; 14():1014150. PubMed ID: 36776842
[TBL] [Abstract][Full Text] [Related]
4. A hypermorphic missense mutation in PLCG2, encoding phospholipase Cγ2, causes a dominantly inherited autoinflammatory disease with immunodeficiency.
Zhou Q; Lee GS; Brady J; Datta S; Katan M; Sheikh A; Martins MS; Bunney TD; Santich BH; Moir S; Kuhns DB; Long Priel DA; Ombrello A; Stone D; Ombrello MJ; Khan J; Milner JD; Kastner DL; Aksentijevich I
Am J Hum Genet; 2012 Oct; 91(4):713-20. PubMed ID: 23000145
[TBL] [Abstract][Full Text] [Related]
5. Expanding the clinical features of autoinflammation and phospholipase Cγ2-associated antibody deficiency and immune dysregulation by description of a novel patient.
Morán-Villaseñor E; Saez-de-Ocariz M; Torrelo A; Arostegui JI; Yamazaki-Nakashimada MA; Alcántara-Ortigoza MA; González-Del-Angel A; Velázquez-Aragón JA; López-Herrera G; Berrón-Ruiz L; García-Romero MT
J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2334-2339. PubMed ID: 31465591
[TBL] [Abstract][Full Text] [Related]
6. A Germline Mutation in the C2 Domain of PLCγ2 Associated with Gain-of-Function Expands the Phenotype for PLCG2-Related Diseases.
Novice T; Kariminia A; Del Bel KL; Lu H; Sharma M; Lim CJ; Read J; Lugt MV; Hannibal MC; O'Dwyer D; Hosler M; Scharnitz T; Rizzo JM; Zacur J; Priatel J; Abdossamadi S; Bohm A; Junker A; Turvey SE; Schultz KR; Rozmus J
J Clin Immunol; 2020 Feb; 40(2):267-276. PubMed ID: 31853824
[TBL] [Abstract][Full Text] [Related]
7. Connecting two pathways through Ca 2+ signaling: NLRP3 inflammasome activation induced by a hypermorphic PLCG2 mutation.
Chae JJ; Park YH; Park C; Hwang IY; Hoffmann P; Kehrl JH; Aksentijevich I; Kastner DL
Arthritis Rheumatol; 2015 Feb; 67(2):563-7. PubMed ID: 25418813
[TBL] [Abstract][Full Text] [Related]
8. Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations.
Martín-Nalda A; Fortuny C; Rey L; Bunney TD; Alsina L; Esteve-Solé A; Bull D; Anton MC; Basagaña M; Casals F; Deyá A; García-Prat M; Gimeno R; Juan M; Martinez-Banaclocha H; Martinez-Garcia JJ; Mensa-Vilaró A; Rabionet R; Martin-Begue N; Rudilla F; Yagüe J; Estivill X; García-Patos V; Pujol RM; Soler-Palacín P; Katan M; Pelegrín P; Colobran R; Vicente A; Arostegui JI
J Clin Immunol; 2020 Oct; 40(7):987-1000. PubMed ID: 32671674
[TBL] [Abstract][Full Text] [Related]
9. PLCG2-associated immune dysregulation (PLAID) comprises broad and distinct clinical presentations related to functional classes of genetic variants.
Baysac K; Sun G; Nakano H; Schmitz EG; Cruz AC; Fisher C; Bailey AC; ; Mace E; Milner JD; Ombrello MJ
J Allergy Clin Immunol; 2024 Jan; 153(1):230-242. PubMed ID: 37769878
[TBL] [Abstract][Full Text] [Related]
10. A new report of autoinflammation and PLCG2-associated antibody deficiency and immune dysregulation (APLAID) with a homozygous pattern from Iran.
Khabbazi A; Rahbar Kafshboran H; Nasiri Aghdam M; Nouri Nojadeh J; Daghagh H; Daneshmandpour Y; Kazemzadeh M; Hamzeiy H; Sakhinia E
Immunol Lett; 2020 May; 221():27-32. PubMed ID: 32014489
[TBL] [Abstract][Full Text] [Related]
11. A novel likely pathogenic PLCG2 variant in a patient with a recurrent skin blistering disease and B-cell lymphopenia.
Park HS; Oh A; Keum CW; Lee J; Lee JK; Son BR; Shin KS; Hahn YS
Eur J Med Genet; 2022 Jan; 65(1):104387. PubMed ID: 34768012
[TBL] [Abstract][Full Text] [Related]
12. Variant in the
Welzel T; Oefelein L; Holzer U; Müller A; Menden B; Haack TB; Groβ M; Kuemmerle-Deschner JB
J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35955991
[TBL] [Abstract][Full Text] [Related]
13. Severe epidermolysis bullosa/Kindler syndrome-like phenotype of an autoinflammatory syndrome in a child.
Mahajan R; Bishnoi A; Manjunath S; Vignesh P; Suri D; Gopal M; Chatterjee D; Jamwal M; De D; Das R; Handa S; Kubba A; Batrani M; Radotra BD
Clin Exp Dermatol; 2021 Jun; 46(4):795-799. PubMed ID: 33625737
[TBL] [Abstract][Full Text] [Related]
14. G-CSF drives autoinflammation in APLAID.
Mulazzani E; Kong K; Aróstegui JI; Ng AP; Ranathunga N; Abeysekera W; Garnham AL; Ng SL; Baker PJ; Jackson JT; Lich JD; Hibbs ML; Wicks IP; Louis C; Masters SL
Nat Immunol; 2023 May; 24(5):814-826. PubMed ID: 36997670
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne: A Single-Center Experience and Literature Review.
Wang Y; Wu N; Yu K; Shen M
Front Immunol; 2021; 12():735851. PubMed ID: 34745107
[TBL] [Abstract][Full Text] [Related]
16. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
17. Ocular Manifestations of Inherited Phospholipase-Cγ2-Associated Antibody Deficiency and Immune Dysregulation.
Di Zazzo A; Tahvildari M; Florakis GJ; Dana R
Cornea; 2016 Dec; 35(12):1656-1657. PubMed ID: 27442322
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil Phospholipase Cγ2 Drives Autoantibody-Induced Arthritis Through the Generation of the Inflammatory Microenvironment.
Futosi K; Kása O; Szilveszter KP; Mócsai A
Arthritis Rheumatol; 2021 Sep; 73(9):1614-1625. PubMed ID: 33645887
[TBL] [Abstract][Full Text] [Related]
19. Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2 deletions.
Ombrello MJ; Remmers EF; Sun G; Freeman AF; Datta S; Torabi-Parizi P; Subramanian N; Bunney TD; Baxendale RW; Martins MS; Romberg N; Komarow H; Aksentijevich I; Kim HS; Ho J; Cruse G; Jung MY; Gilfillan AM; Metcalfe DD; Nelson C; O'Brien M; Wisch L; Stone K; Douek DC; Gandhi C; Wanderer AA; Lee H; Nelson SF; Shianna KV; Cirulli ET; Goldstein DB; Long EO; Moir S; Meffre E; Holland SM; Kastner DL; Katan M; Hoffman HM; Milner JD
N Engl J Med; 2012 Jan; 366(4):330-8. PubMed ID: 22236196
[TBL] [Abstract][Full Text] [Related]
20. PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report.
Maggio MC; Ceccherini I; Grossi A; Gattorno M; Corsello G
Ital J Pediatr; 2019 Aug; 45(1):111. PubMed ID: 31443670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
